Literature DB >> 22557727

Discontinuous type of splenogonadal fusion syndrome with limb defects.

Vivek Patre1, Satyabhuwan Netam, Pankaj Luka, Hulesh Mandle.   

Abstract

Splenogonadal fusion is a rare congenital anomaly. We report a case of discontinuous type of splenogonadal fusion with congenital malformation. We focused here to avoid unnecessary orchidectomy by cementing the base of preoperative scrotal ultrasonography, for paratesticular masses.

Entities:  

Keywords:  Orchidectomy; paratesticular mass; splenogonadal fusion; syndactyly; ultrasonography

Year:  2012        PMID： 22557727      PMCID： PMC3339797          DOI： 10.4103/0970-1591.94966

Source DB:  PubMed          Journal:  Indian J Urol        ISSN： 0970-1591


  6 in total

Review 1.  Splenogonadal fusion: is the accepted classification system accurate?

Authors:  P J Le Roux; R M Heddle
Journal:  BJU Int       Date:  2000-01       Impact factor: 5.588

2.  [Spleen tissue in the left ovary of the left individual part of a human thoracopagus].

Authors:  A von HOCHSTETTER
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1953

3.  An Apparent Third Testicle consisting of a Scrotal Spleen.

Authors:  W A Sneath
Journal:  J Anat Physiol       Date:  1913-04

4.  [Intra-scrotal supernumerary spleen. A long silent case of discontinuous spleno-gonadal fusion].

Authors:  J Diebold; O Le Blaye; A Le Tourneau; P Marichez
Journal:  Ann Pathol       Date:  1990       Impact factor: 0.407

Review 5.  One hundred years of splenogonadal fusion.

Authors:  A M Carragher
Journal:  Urology       Date:  1990-06       Impact factor: 2.649

Review 6.  Splenogonadal fusion: report of 2 cases and review of the literature.

Authors:  M I Karaman; E T Gonzales
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450
  6 in total
  1 in total

Review 1.  Splenogonadal fusion: a case report and review of the literature.

Authors:  Guangjie Chen; Xiaohao Wang; Yijun Zhao; Linfeng Zhu; Daxing Tang
Journal:  BMC Urol       Date:  2021-02-03       Impact factor: 2.264
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.